All clinical development activities to bring GW501516 to market were stopped when toxicities, including various cancers, were discovered following routine, long-term animal studies
SLC25A10 and SLC25A11, also known as the mitochondrial dicarboxylate and oxoglutarate carriers, respectively, were initially proposed as the proteins responsible for GSH transport into mitochondria over 25 years ago [12]
"Advances in kilovoltage x-ray beam dosimetry"
503A pharmacies on a patient-specific prescription basis
Understanding your genetic predisposition to inflammation can help inform personalized treatment strategies
Self-controlled case series (SCCS) + Among semaglutide users who experience incident vulvovaginitis, candidiasis, or bleeding diagnoses, compare within-person incidence in defined risk windows after each dose escalation vs baseline periods, reducing fixed confounding